National Academies Press: OpenBook

Molybdenum-99 for Medical Imaging (2016)

Chapter: Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses

« Previous: Appendix C: Presentations and Site Visits
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
All Nuclear Medicine Diagnostic HCPCS Category
All Tc-99m diagnostic Tc-99m MPI diagnostic All non-Tc-99m/non-PET diagnostic All PET diagnostic Nuclear medicine diagnostic (non-PET)
Sestamibi (Cardiolite) A9500 X X X
Tetrofosmin (Myoview) A9502 X X X
Tl-201 chloride A9505 X X
N-13 ammonia A9526 X
Rb-82, diagnostic, per study dose to 60 mCi A9555 X
Medronate (MDP) A9503 X X
Tc-99m Oxidronate (TechneScan, HDP) A9561 X X
Pyrophosphate A9538 X X
Sodium fluoride F-18, diagnostic, per study dose, up to 30 millicuries A9580 X
Disofenin (Hepatolite) A9510 X X
Mebrofenin (Choletec) A9537 X X
Mertiatide (MAG-3) A9562 X X
Succimer (DMSA) A9551 X X
Tc-99m glucoheptonate (glucoheptate) A9550 X X
Tc-99m pentatate (DTPA) A9539 X X
I-125 sodium iothalamate (Glofil-125) A9554 X X
I-123 NaI, per 100 uCi, capsules, diagnostic A9516 X X
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
I-123 NaI per mCi, diagnostic A9509 X X
I-131 NaI capsule per mCi, diagnostic A9528 X X
I-131 NaI solution per mCi, diagnostic A9529 X X
I-131 NaI per uCi A9531 X X
Pertechnetate per mCi A9512 X X
Macroaggregated albumin (MAA) A9540 X X
Xe-133 A9558 X X
Tc-99m pentatate aerosol A9567 X X
In-111 pentetreotide (Octreoscan) A9565/9572 X X
I-131 iobenguane (MIBG), diagnostic, per 0.5 mCi A9508 X X
I -123 iobenguane MIBG, diagnostic, up to 15 mCi A9582 X X
Fluorodeoxyglucose F-18 FDG, diagnostic A9552 X
Exametazime (Ceretec) A9521 X X
Bicisate (Neurolite) A9557 X X X
I-123 ioflupane (DATscan) A9584 X
In-111 Pentetate, Diagnostic CSF, per 0.5 mCi A9548 X
F18 Florbetapir (Amyvid) A9586 X
In-111 oxyquinoline (oxine) A9547 X X
Exametazime (HMPAO) autologous WBC’s A9569 X X
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
All Nuclear Medicine Diagnostic HCPCS Category
All Tc-99m diagnostic Tc-99m MPI diagnostic All non-Tc-99m/non-PET diagnostic All PET diagnostic Nuclear medicine diagnostic (non-PET)
In-111 labeled autologous WBC’s A9570 X
Sulfur colloid A9541 X X
Labeled red cells A9560 X X
Ga-67 citrate per mCi A9556 X X
In-111 ibiritumomab tiuxetan (Zevalin), diagnostic A9542 X X
I-131 tositumomab (Bexxar), diagnostic A9544 X X
Co57/58 cyanocobalamin A9546 X X
Cr-51 sodium chromate A9553 X X
Co-57 cyanocobalamin A9559 X X
Arcitumomab (CEA Scan) A9568 X X
In-111 capromab pendetide (Prostascint) A9507 X X
In-111 labeled autologous platelets A9571 X X
I-131 human serum albumin A9524 X X

NOTE: Categories correspond to the labels used in Figures 6.1-6.3 and 6.6 and 6.7 in Chapter 6.

Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
Page 237
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
Page 238
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
Page 239
Suggested Citation:"Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses." National Academies of Sciences, Engineering, and Medicine. 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press. doi: 10.17226/23563.
×
Page 240
Next: Appendix E: Acronyms »
Molybdenum-99 for Medical Imaging Get This Book
×
Buy Paperback | $75.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical diagnostic imaging or therapy. The United States consumes about half of the world’s supply of Mo-99, but there has been no domestic (i.e., U.S.-based) production of this isotope since the late 1980s. The United States imports Mo-99 for domestic use from Australia, Canada, Europe, and South Africa.

Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!